Patents Assigned to IXMEDICINE (XIAMEN) BIOLOGICAL TECHNOLOGY COMPANY LIMITED
  • Ligand for orphan nuclear receptor Nur77 and uses thereof
    Patent number: 10808005
    Abstract: Provided are use of a compound of Formula I as a ligand of orphan nulear receptor Nur77, and in the prevention or treatment of a orphan nulear receptor Nur77 associated disease,
    Type: Grant
    Filed: July 4, 2017
    Date of Patent: October 20, 2020
    Assignee: IXMEDICINE (XIAMEN) BIOLOGICAL TECHNOLOGY COMPANY LIMITED
    Inventors: Xiaokun Zhang, Xiangzhi Lin, Ying Su, Zhiping Zeng, Mengjie Hu, Qiang Luo, Yi Zhu, Alitongbieke Gulimiran